Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept

A formulation of aflibercept for intravitreal injection (Eylea) is approved for the treatment of patients with exudative age-related macular degeneration (AMD). Aflibercept has a significantly higher affinity for Vascular endothelial growth factor (VEGF)-A compared with other monoclonal anti-VEGF an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs Aging
Autores principales: García-Layana, Alfredo, Figueroa, Marta S., Araiz, Javier, Ruiz-Moreno, José M., Gómez-Ulla, Francisco, Arias-Barquet, Luis, Reiter, Nicholas
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607716/
https://ncbi.nlm.nih.gov/pubmed/26442858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-015-0300-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares